Alphamab Oncology (HKSE:09966) Ending Cash Position : HK$1,187.8 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology Ending Cash Position?

Alphamab Oncology's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$1,187.8 Mil.

Alphamab Oncology's quarterly Ending Cash Position increased from Dec. 2022 (HK$1,194.0 Mil) to Jun. 2023 (HK$1,242.9 Mil) but then declined from Jun. 2023 (HK$1,242.9 Mil) to Dec. 2023 (HK$1,187.8 Mil).

Alphamab Oncology's annual Ending Cash Position increased from Dec. 2021 (HK$983.6 Mil) to Dec. 2022 (HK$1,194.0 Mil) but then declined from Dec. 2022 (HK$1,194.0 Mil) to Dec. 2023 (HK$1,187.8 Mil).

Alphamab Oncology Ending Cash Position Historical Data

The historical data trend for Alphamab Oncology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Ending Cash Position Chart

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,078.47

219.69

983.62

1,193.98

1,187.83

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial								983.62	1,145.67	1,193.98	1,242.87	1,187.83

Alphamab Oncology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alphamab Oncology's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1169.456	+	18.375
	=	1,187.8

Alphamab Oncology's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1242.864	+	-55.033
	=	1,187.8

Alphamab Oncology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology (HKSE:09966) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

3NK:Germany

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024

Website

https://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines